Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis

Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis

Background: Bacterial vaginosis—a condition defined by a shift from Lactobacillus dominance to a polymicrobial, anaerobic bacterial community—increases the risk of acquiring sexually transmitted infections and other complications of the female reproductive tract. Antibiotic treatment frequently fail...

Full description

Bibliographic Details
Main Authors: Alcaide, M. (Author), Chandra, N. (Author), Doncel, G.F (Author), Fichorova, R. (Author), Gale, M., Jr (Author), Gustin, A.T (Author), Klatt, N.R (Author), Schifanella, L. (Author), Thurman, A.R (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
adult
Adult
Anti-Bacterial Agents
antibiotics
antiinfective agent
bacterial vaginosis recurrence
biofilms
female
Female
human
Humans
Lactobacillus
Longitudinal Studies
longitudinal study
metronidazole
Metronidazole
microbiology
Microbiota
microflora
molecular bacterial vaginosis
mucosal immunity
Recurrence
recurrent disease
treatment failure
Treatment Failure
vagina
Vagina
vaginal microbiome
vaginitis
Vaginosis, Bacterial
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items